China Shineway Pharmaceutical Group Limited (CSWYY)

CSWYY Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	944	938	703	735	667	517
Market Cap Growth	16.43%	33.50%	-4.39%	10.17%	29.15%	-29.47%
Enterprise Value	16	125	3	69	29	26
Last Close Price	19.00	17.15	15.65	10.09	14.35	14.35
PE Ratio	8.17	8.15	5.14	7.02	7.62	11.44
PS Ratio	2.02	1.81	1.10	1.28	1.32	1.27
PB Ratio	0.87	0.92	0.71	0.80	0.72	0.58
P/TBV Ratio	0.89	0.94	0.73	0.82	0.75	0.60
P/FCF Ratio	8.46	8.32	6.32	5.17	6.96	5.89
P/OCF Ratio	7.01	7.11	5.35	4.57	6.03	5.28
EV/Sales Ratio	0.03	0.24	0.01	0.12	0.06	0.06
EV/EBITDA Ratio	0.16	1.02	0.02	0.54	0.26	0.27
EV/EBIT Ratio	0.18	1.09	0.02	0.67	0.34	0.40
EV/FCF Ratio	0.14	1.10	0.03	0.48	0.30	0.29
Debt / Equity Ratio	0.04	0.05	0.04	0.00	0.00	0.07
Debt / EBITDA Ratio	0.48	0.38	0.29	0.01	0.02	0.62
Debt / FCF Ratio	0.43	0.42	0.38	0.01	0.02	0.69
Asset Turnover	0.33	0.39	0.51	0.51	0.45	0.37
Inventory Turnover	1.15	1.11	1.44	1.63	1.58	1.53
Quick Ratio	3.36	3.17	2.97	3.66	4.62	3.96
Current Ratio	3.69	3.51	3.35	4.07	5.19	4.62
Return on Equity (ROE)	10.94%	11.59%	14.45%	11.77%	9.52%	5.10%
Return on Assets (ROA)	3.98%	5.33%	6.81%	5.78%	4.63%	3.68%
Return on Invested Capital (ROIC)	42.51%	44.71%	54.89%	36.93%	20.95%	14.18%
Return on Capital Employed (ROCE)	8.10%	11.00%	13.60%	10.90%	8.80%	7.00%
Earnings Yield	12.25%	12.26%	19.45%	14.25%	13.13%	8.74%
FCF Yield	11.82%	12.02%	15.81%	19.33%	14.37%	16.97%
Dividend Yield	6.02%	0.43%	0.38%	0.46%	0.43%	0.34%
Payout Ratio	42.87%	48.56%	32.73%	33.45%	81.39%	58.83%
Buyback Yield / Dilution	-	-	-	-0.03%	0.21%	3.10%
Total Shareholder Return	6.02%	0.43%	0.38%	0.43%	0.64%	3.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.